Stay updated with breaking news from Kumar Budur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript April 30, 2024 Harmony Biosciences Holdings, Inc. beats earnings expectations. Reported EPS is $0.666, expectations were $0.64. Harmony Biosciences Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
HRMY earnings call for the period ending March 31, 2024.
The study will evaluate pitolisant for treating excessive daytime sleepiness and behavioral symptoms in patients with Prader-Willi syndrome.
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY) has initiated its global Phase 3 registrational trial, the TEMPO study, to...
Harmony Biosciences Holdings, Inc. misses on earnings expectations. Reported EPS is $0.45 EPS, expectations were $0.74. Harmony Biosciences Holdings, Inc.